Protagenic Therapeutics, Inc.\new
PTIX· OTC
PTIXProtagenic Therapeutics, Inc.\new
Filed Mar 31, 2023 · 10-K · 90 days after period end · 0001493152-23-010152
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$601.37K | -$890.39K | -$436.68K | -$749.87K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protagenic Therapeutics, Inc.\new · CIK 1022899 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 31, 2023 · 90 d after period end
